4baseCare
Dr. Anjali Kulkarni is a seasoned professional in the field of clinical informatics and oncology, currently serving as the VP of RWE Strategy and Analytics at 4baseCare since April 2024. Dr. Kulkarni's extensive experience includes a previous role as VP of Clinical Informatics at Karkinos Healthcare, where responsibilities involved building a multimodal oncology data repository and successfully completing clinical data analytics projects for large tertiary hospitals. Additional positions held include Clinical Implementation Leader for Oncology at IBM's Watson Health, Senior Manager of Strategic Medical Affairs at Boston Scientific, and various roles in clinical excellence and healthcare consulting at companies such as PERFINT HEALTHCARE and Philips Healthcare. Dr. Kulkarni's academic credentials include degrees in Clinical Oncology and Medicine, with advanced training in management and entrepreneurship from prestigious institutions such as the Indian Institute of Management Bangalore and the National University of Singapore.
This person is not in the org chart
This person is not in any teams
4baseCare
4baseCare, an Illumina-backed Company* headquartered in Singapore, is engaged in developing cutting-edge Precision Oncology Solutions using Advanced Genomics and Next-Gen digital health technology. Taking into consideration that the clinical outcome could significantly vary across different populations, we have developed a unique set of indigenous comprehensive cancer gene panels that enables oncologists to choose the optimal precision therapies for their patients. Our coveted genomic testing portfolio assesses the tumour genomic alterations by NGS from Tissue or Liquid biopsy for Somatic Mutation Analysis and Germline Mutation Testing for Hereditary and Familial Cancer from peripheral blood to personalize patient care in Oncology. *Part of Illumina Accelerator 10th Cycle